Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
YCBD

YCBD - cbdMD Inc Stock Price, Fair Value and News

$0.77-0.01 (-1.28%)
Market Closed

65/100

YCBD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

65/100

YCBD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.14

Target 3M

$0.92

Target 6M

$0.99

YCBD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

YCBD Price Action

Last 7 days

-2.5%

Last 30 days

-43.4%

Last 90 days

-12.5%

Trailing 12 Months

-83.8%

YCBD RSI Chart

YCBD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

YCBD Valuation

Market Cap

8.0M

Price/Earnings (Trailing)

-3.92

Price/Sales (Trailing)

0.42

EV/EBITDA

-3.49

Price/Free Cashflow

-4.89

YCBD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.14

Target 3M

$0.92

Target 6M

$0.99

YCBD Fundamentals

YCBD Revenue

Revenue (TTM)

19.2M

Rev. Growth (Yr)

3.61%

Rev. Growth (Qtr)

2.48%

YCBD Earnings

Earnings (TTM)

-2.0M

Earnings Growth (Yr)

-345.01%

Earnings Growth (Qtr)

24.05%

YCBD Profitability

Operating Margin

62.37%

EBT Margin

-10.63%

Return on Equity

-28.24%

Return on Assets

-19.59%

Free Cashflow Yield

-20.44%

YCBD Investor Care

Shares Dilution (1Y)

1259.44%

Diluted EPS (TTM)

-1.09

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202519.6M19.0M19.2M0
202422.4M21.1M19.9M19.7M
202330.1M27.7M25.1M24.2M
202241.5M39.1M37.1M33.5M
202148.6M49.2M47.3M44.1M
202039.8M40.8M43.2M45.9M
201914.3M21.2M28.1M37.8M
20186.8M8.2M459.1K7.4M
20174.0M4.7M5.4M5.7M
2016002.6M3.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About cbdMD Inc

YCBD
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
 CEO
 WEBSITEcbdmd.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES90

cbdMD Inc Frequently Asked Questions

YCBD is the stock ticker symbol of cbdMD Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of cbdMD Inc is 8.01 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check YCBD's fair value in chart for subscribers.

The fair value guage provides a quick view whether YCBD is over valued or under valued. Whether cbdMD Inc is cheap or expensive depends on the assumptions which impact cbdMD Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for YCBD.

As of Wed Jan 28 2026, YCBD's PE ratio (Price to Earnings) is -3.92 and Price to Sales (PS) ratio is 0.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. YCBD PE ratio will change depending on the future growth rate expectations of investors.